![John F. Burd](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John F. Burd
Hoofd Techniek/Wetenschap/O&O bij
Freedom Meditech, Inc.
Profiel
John F.
Burd is the founder.
He founded Oculir, Inc. in 2003 and DexCom, Inc. in 1999.
At Oculir, Inc., he held the title of President & Chief Executive Officer in 2008.
At DexCom, Inc., he also held the title of President & Chief Executive Officer from 1999 to 2002.
Dr. Burd is also the founder of LXN Corp.
Dr. Burd's current job is at Freedom Meditech, Inc. where he started in 2008 and currently holds the position of Chief Science Officer.
Dr. Burd's former jobs include Vice President-Research & Development at Quidel Corp., Principal at Bayer Corp., Chief Operating Officer & Executive Vice President at MAST Immunosystems, Inc., and General Partner at Windamere Venture Partners LLC.
Dr. Burd's education includes an undergraduate degree from Purdue University and graduate and doctorate degrees from the University of Wisconsin.
Dr. Burd is also the founder of LXN Corp.
Actieve functies van John F. Burd
| Bedrijven | Functie | Begin |
|---|---|---|
Freedom Meditech, Inc.
 Freedom Meditech, Inc. Medical SpecialtiesHealth Technology Provides development and commercialization of ophthalmic medical devices | Hoofd Techniek/Wetenschap/O&O | 01-10-2010 |
Eerdere bekende functies van John F. Burd
| Bedrijven | Functie | Einde |
|---|---|---|
Oculir, Inc.
 Oculir, Inc. Medical SpecialtiesHealth Technology Develops medical devices | Algemeen Directeur | 23-10-2008 |
Windamere Venture Partners LLC
 Windamere Venture Partners LLC Investment ManagersFinance Windamere Venture Partners invests in seed and early-stage companies. The firm target companies are product-focused healthcare companies in the areas of emerging pharmaceuticals, specialty pharmaceuticals and medical devices. | Corporate Officer/Principal | 31-12-2007 |
| DEXCOM, INC. | Algemeen Directeur | 01-01-2002 |
Bayer Corp.
 Bayer Corp. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical, healthcare & agricultural products | Corporate Officer/Principal | - |
MAST Immunosystems, Inc.
 MAST Immunosystems, Inc. Medical SpecialtiesHealth Technology Develops innovative medical diagnostics and equipment | Operationeel Directeur | - |
Opleiding van John F. Burd
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
23
Eerstegraads connecties
10
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 10 |
|---|---|
Quidel Corp.
 Quidel Corp. Medical SpecialtiesHealth Technology Provides diagnostic healthcare solutions | Health Technology |
Bayer Corp.
Bayer Corp. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical, healthcare & agricultural products | Health Technology |
LXN Corp
 LXN Corp Pharmaceuticals: MajorHealth Technology Develops and commercializes fructosamine monitoring technology for diabetes | Health Technology |
Oculir, Inc.
Oculir, Inc. Medical SpecialtiesHealth Technology Develops medical devices | Health Technology |
MAST Immunosystems, Inc.
MAST Immunosystems, Inc. Medical SpecialtiesHealth Technology Develops innovative medical diagnostics and equipment | Health Technology |
DexCom, Inc.
 DexCom, Inc. Medical SpecialtiesHealth Technology Designs, develops and commercializes continuous glucose monitoring systems for management of diabetes & metabolic health by patients, caregivers and clinicians | Health Technology |
Purdue University
 Purdue University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Wisconsin
 University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Windamere Venture Partners LLC
Windamere Venture Partners LLC Investment ManagersFinance Windamere Venture Partners invests in seed and early-stage companies. The firm target companies are product-focused healthcare companies in the areas of emerging pharmaceuticals, specialty pharmaceuticals and medical devices. | Finance |
Freedom Meditech, Inc.
Freedom Meditech, Inc. Medical SpecialtiesHealth Technology Provides development and commercialization of ophthalmic medical devices | Health Technology |
